WO1998040749A1 - Procede de detection de la vasculopathie - Google Patents

Procede de detection de la vasculopathie Download PDF

Info

Publication number
WO1998040749A1
WO1998040749A1 PCT/JP1998/001005 JP9801005W WO9840749A1 WO 1998040749 A1 WO1998040749 A1 WO 1998040749A1 JP 9801005 W JP9801005 W JP 9801005W WO 9840749 A1 WO9840749 A1 WO 9840749A1
Authority
WO
WIPO (PCT)
Prior art keywords
creatine kinase
activity
measured
vasculopathy
kinase isozyme
Prior art date
Application number
PCT/JP1998/001005
Other languages
English (en)
Japanese (ja)
Inventor
Tohru Suzuki
Masaru Hamaoki
Hirohisa Katho
Original Assignee
Yamasa Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corporation filed Critical Yamasa Corporation
Priority to AU63095/98A priority Critical patent/AU6309598A/en
Publication of WO1998040749A1 publication Critical patent/WO1998040749A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/50—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving creatine phosphokinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine

Abstract

Cette invention se rapporte à un procédé de détection de la vasculopathie qui consiste à évaluer les quantités, le rapport relatif ou le rapport d'activité de trois iso-enzymes créatine kinases (BB, MB et MM) dans des échantillons prélevés chez des sujets et à comparer les valeurs obtenues aux données correspondantes des iso-enzymes chez des personnes normales aux fins de détection de la vasculopathie chez les sujets en question.
PCT/JP1998/001005 1997-03-12 1998-03-11 Procede de detection de la vasculopathie WO1998040749A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU63095/98A AU6309598A (en) 1997-03-12 1998-03-11 Method for detecting vasculopathy

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP9/76480 1997-03-12
JP7648097 1997-03-12
JP9/93014 1997-03-27
JP9301497 1997-03-27

Publications (1)

Publication Number Publication Date
WO1998040749A1 true WO1998040749A1 (fr) 1998-09-17

Family

ID=26417629

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1998/001005 WO1998040749A1 (fr) 1997-03-12 1998-03-11 Procede de detection de la vasculopathie

Country Status (2)

Country Link
AU (1) AU6309598A (fr)
WO (1) WO1998040749A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01257266A (ja) * 1988-04-06 1989-10-13 Unitika Ltd クレアチンキナーゼ活性測定用試薬およびそれを用いる測定方法
JPH0499499A (ja) * 1990-08-17 1992-03-31 Unitika Ltd 総クレアチンキナーゼ，クレアチンキナーゼ―アイソフオーム活性同時測定用試薬
JPH06189760A (ja) * 1992-09-14 1994-07-12 E I Du Pont De Nemours & Co クレアチンキナーゼおよびクレアチンキナーゼイソ酵素の酵素活性および免疫反応性を安定させるための組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01257266A (ja) * 1988-04-06 1989-10-13 Unitika Ltd クレアチンキナーゼ活性測定用試薬およびそれを用いる測定方法
JPH0499499A (ja) * 1990-08-17 1992-03-31 Unitika Ltd 総クレアチンキナーゼ，クレアチンキナーゼ―アイソフオーム活性同時測定用試薬
JPH06189760A (ja) * 1992-09-14 1994-07-12 E I Du Pont De Nemours & Co クレアチンキナーゼおよびクレアチンキナーゼイソ酵素の酵素活性および免疫反応性を安定させるための組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHAZOUILLERES O. et al., "Creatine Kinase-BB and Soluble Thrombomodulin: New Markers for Sinusoidal Damage in Human Liver Transplantation", ANN. NEW YORK ACAD. SCI., Vol. 723, (1984), p. 466-469. *

Also Published As

Publication number Publication date
AU6309598A (en) 1998-09-29

Similar Documents

Publication Publication Date Title
Freda et al. Cardiac troponins in renal insufficiency: review and clinical implications
Khan et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis
EP2347266B1 (fr) Pronostic et évaluation du risque chez des patients souffrant d insuffisance cardiaque par détermination du taux de adm
US10067063B2 (en) Prognosis and risk assessment in stroke patients by determining the level of marker peptides
Niizeki et al. Circulating levels of heart-type fatty acid-binding protein in a general Japanese population effects of age, gender and physiologic characteristics
US20150233947A1 (en) Body Fluid BIN1 as a Marker of Cardiac Health
Muzyk et al. Use of cardiac troponin in the early diagnosis of acute myocardial infarction
Lin et al. Plasma fibroblast growth factor 23 is elevated in pediatric primary hypertension
WO1998040749A1 (fr) Procede de detection de la vasculopathie
Velibey et al. Determination of a predictive cutoff value of NT-proBNP testing for long-term survival in ED patients with acute heart failure
US20140213597A1 (en) Methods of Predicting and Treating Adverse Cardiac Events
Apple Cardiac troponin I
EP3311164B1 (fr) Méthodes et compositions pour le diagnostic et le pronostic de l'appendicite et la différenciation des causes de la douleur abdominale
CN111065922A (zh) 肾上腺髓质素原作为危重病患者的肾脏替代治疗的指标
Ratzmann et al. Further evidence for tubular dysfunction in insulin dependent diabetes
Ammar et al. Impaired functional status and echocardiographic abnormalities signifying global dysfunction enhance the prognostic significance of previously unrecognized myocardial infarction detected by electrocardiography
Ghanayem et al. Urinary 8-hydroxy-2′-deoxyguanosine as an oxidative DNA damage biomarker in chronic heart failure
Johnson et al. Differential laboratory diagnosis of hypercalcemia
JP2008516218A (ja) 急性冠症候群の疑いを除外するｉｎｖｉｔｒｏ診断方法
Gioia et al. Transthyretin amyloid cardiomyopathy among patients with heart failure and preserved ejection fraction: the AMY score
Rabih et al. DIRECTIVES/GUIDELINES
Elzamarany et al. Evaluation of cardiac specific Troponin I levels for diagnosis and prediction the risk of mortality in patients with acute coronary syndrome
Hänseler et al. A new rapid and sensitive immunofluorescence assay for the determination of myoglobin in serum
Laterza PAPP-A: a marker of plaque instability. Is it ready for prime time?
Overturf et al. Renin activity, sodium and potassium in hypertensive patients

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA